Outlook Therapeutics Shares Are Trading Higher After BTIG Upgraded the Stock From Neutral to Buy and Announced a $50 Price Target
在BTIG將股票從中性上調至買入並宣佈50美元的目標股價之後,Outlook Therapeutics的股價走高
Outlook Therapeutics Shares Are Trading Higher After BTIG Upgraded the Stock From Neutral to Buy and Announced a $50 Price Target
在BTIG將股票從中性上調至買入並宣佈50美元的目標股價之後,Outlook Therapeutics的股價走高
使用瀏覽器的分享功能,分享給你的好友吧